Selected research
Industry Research
Lithium Medication Industry Research Report 2026
Market perspective
The global Lithium Medication market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lithium Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lithium Medication is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lithium Medication is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lithium Medication include Takeda, Eli Lilly, Pfizer, GlaxoSmithKline, Astrazeneca, Shionogi, Otsuka Pharmaceutical, NHU Group and Lundbeck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lithium Medication market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lithium Medication Market by Company
Takeda
Eli Lilly
Pfizer
GlaxoSmithKline
Astrazeneca
Shionogi
Otsuka Pharmaceutical
NHU Group
Lundbeck
Kanghong Pharma
Intellipharmaceutics
HUAHAI
Bristol-Myers Squibb
APOTEX
Allergan
Lithium Medication Segment by Type
Tablets
Oral Solution
Capsules
Lithium Medication Segment by Application
Hospital
Clinic
Others
Lithium Medication Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lithium Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lithium Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lithium Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lithium Medication manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lithium Medication by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lithium Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Oral Solution
- Capsules
Applications
- Hospital
- Clinic
- Others
Companies covered
- Takeda
- Eli Lilly
- Pfizer
- GlaxoSmithKline
- Astrazeneca
- Shionogi
- Otsuka Pharmaceutical
- NHU Group
- Lundbeck
- Kanghong Pharma
- Intellipharmaceutics
- HUAHAI
- Bristol-Myers Squibb
- APOTEX
- Allergan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lithium Medication Market Size (2021-2032)
- 2.2.2 Global Lithium Medication Sales (2021-2032)
- 2.2.3 Global Lithium Medication Market Average Price (2021-2032)
- 2.3 Lithium Medication by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Oral Solution
- 2.3.4 Capsules
- 2.4 Lithium Medication by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lithium Medication Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lithium Medication Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Lithium Medication Revenue of Manufacturers (2021-2026)
- 3.4 Global Lithium Medication Average Price by Manufacturers (2021-2026)
- 3.5 Global Lithium Medication Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lithium Medication, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lithium Medication, Product Type & Application
- 3.8 Global Manufacturers of Lithium Medication, Established Date
- 3.9 Global Lithium Medication Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda
- 4.1.1 Takeda Company Information
- 4.1.2 Takeda Business Overview
- 4.1.3 Takeda Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda Lithium Medication Product Portfolio
- 4.1.5 Takeda Recent Developments
- 4.2 Eli Lilly
- 4.2.1 Eli Lilly Company Information
- 4.2.2 Eli Lilly Business Overview
- 4.2.3 Eli Lilly Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eli Lilly Lithium Medication Product Portfolio
- 4.2.5 Eli Lilly Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Lithium Medication Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 GlaxoSmithKline
- 4.4.1 GlaxoSmithKline Company Information
- 4.4.2 GlaxoSmithKline Business Overview
- 4.4.3 GlaxoSmithKline Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline Lithium Medication Product Portfolio
- 4.4.5 GlaxoSmithKline Recent Developments
- 4.5 Astrazeneca
- 4.5.1 Astrazeneca Company Information
- 4.5.2 Astrazeneca Business Overview
- 4.5.3 Astrazeneca Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Astrazeneca Lithium Medication Product Portfolio
- 4.5.5 Astrazeneca Recent Developments
- 4.6 Shionogi
- 4.6.1 Shionogi Company Information
- 4.6.2 Shionogi Business Overview
- 4.6.3 Shionogi Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shionogi Lithium Medication Product Portfolio
- 4.6.5 Shionogi Recent Developments
- 4.7 Otsuka Pharmaceutical
- 4.7.1 Otsuka Pharmaceutical Company Information
- 4.7.2 Otsuka Pharmaceutical Business Overview
- 4.7.3 Otsuka Pharmaceutical Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Otsuka Pharmaceutical Lithium Medication Product Portfolio
- 4.7.5 Otsuka Pharmaceutical Recent Developments
- 4.8 NHU Group
- 4.8.1 NHU Group Company Information
- 4.8.2 NHU Group Business Overview
- 4.8.3 NHU Group Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 NHU Group Lithium Medication Product Portfolio
- 4.8.5 NHU Group Recent Developments
- 4.9 Lundbeck
- 4.9.1 Lundbeck Company Information
- 4.9.2 Lundbeck Business Overview
- 4.9.3 Lundbeck Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lundbeck Lithium Medication Product Portfolio
- 4.9.5 Lundbeck Recent Developments
- 4.10 Kanghong Pharma
- 4.10.1 Kanghong Pharma Company Information
- 4.10.2 Kanghong Pharma Business Overview
- 4.10.3 Kanghong Pharma Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Kanghong Pharma Lithium Medication Product Portfolio
- 4.10.5 Kanghong Pharma Recent Developments
- 4.11 Intellipharmaceutics
- 4.11.1 Intellipharmaceutics Company Information
- 4.11.2 Intellipharmaceutics Business Overview
- 4.11.3 Intellipharmaceutics Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Intellipharmaceutics Lithium Medication Product Portfolio
- 4.11.5 Intellipharmaceutics Recent Developments
- 4.12 HUAHAI
- 4.12.1 HUAHAI Company Information
- 4.12.2 HUAHAI Business Overview
- 4.12.3 HUAHAI Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 HUAHAI Lithium Medication Product Portfolio
- 4.12.5 HUAHAI Recent Developments
- 4.13 Bristol-Myers Squibb
- 4.13.1 Bristol-Myers Squibb Company Information
- 4.13.2 Bristol-Myers Squibb Business Overview
- 4.13.3 Bristol-Myers Squibb Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Bristol-Myers Squibb Lithium Medication Product Portfolio
- 4.13.5 Bristol-Myers Squibb Recent Developments
- 4.14 APOTEX
- 4.14.1 APOTEX Company Information
- 4.14.2 APOTEX Business Overview
- 4.14.3 APOTEX Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 APOTEX Lithium Medication Product Portfolio
- 4.14.5 APOTEX Recent Developments
- 4.15 Allergan
- 4.15.1 Allergan Company Information
- 4.15.2 Allergan Business Overview
- 4.15.3 Allergan Lithium Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Allergan Lithium Medication Product Portfolio
- 4.15.5 Allergan Recent Developments
5 Global Lithium Medication Market Scenario by Region
- 5.1 Global Lithium Medication Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lithium Medication Sales by Region: 2021-2032
- 5.2.1 Global Lithium Medication Sales by Region: 2021-2026
- 5.2.2 Global Lithium Medication Sales by Region: 2027-2032
- 5.3 Global Lithium Medication Revenue by Region: 2021-2032
- 5.3.1 Global Lithium Medication Revenue by Region: 2021-2026
- 5.3.2 Global Lithium Medication Revenue by Region: 2027-2032
- 5.4 North America Lithium Medication Market Facts & Figures by Country
- 5.4.1 North America Lithium Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lithium Medication Sales by Country (2021-2032)
- 5.4.3 North America Lithium Medication Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Lithium Medication Market Facts & Figures by Country
- 5.5.1 Europe Lithium Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lithium Medication Sales by Country (2021-2032)
- 5.5.3 Europe Lithium Medication Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Lithium Medication Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lithium Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lithium Medication Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lithium Medication Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lithium Medication Market Facts & Figures by Country
- 5.7.1 South America Lithium Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lithium Medication Sales by Country (2021-2032)
- 5.7.3 South America Lithium Medication Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Lithium Medication Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lithium Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lithium Medication Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lithium Medication Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Lithium Medication Sales by Type (2021-2032)
- 6.1.1 Global Lithium Medication Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Lithium Medication Sales Market Share by Type (2021-2032)
- 6.2 Global Lithium Medication Revenue by Type (2021-2032)
- 6.2.1 Global Lithium Medication Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lithium Medication Revenue Market Share by Type (2021-2032)
- 6.3 Global Lithium Medication Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lithium Medication Sales by Application (2021-2032)
- 7.1.1 Global Lithium Medication Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Lithium Medication Sales Market Share by Application (2021-2032)
- 7.2 Global Lithium Medication Revenue by Application (2021-2032)
- 7.2.1 Global Lithium Medication Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lithium Medication Revenue Market Share by Application (2021-2032)
- 7.3 Global Lithium Medication Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lithium Medication Value Chain Analysis
- 8.1.1 Lithium Medication Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lithium Medication Production Mode & Process
- 8.2 Lithium Medication Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lithium Medication Distributors
- 8.2.3 Lithium Medication Customers
9 Global Lithium Medication Analyzing Market Dynamics
- 9.1 Lithium Medication Industry Trends
- 9.2 Lithium Medication Industry Drivers
- 9.3 Lithium Medication Industry Opportunities and Challenges
- 9.4 Lithium Medication Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst